Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

An imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone.

An imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone. Cancer Res. 2007 Apr 15; 67(8):3524-8.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.